• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tribbles假激酶3()通过激活丝裂原活化蛋白激酶途径促进肝细胞癌的进展。

Tribbles pseudokinase 3 () contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.

作者信息

Wang Rui-Qi, He Fa-Zhong, Meng Qian, Lin Wei-Jie, Dong Jia-Mei, Yang Hai-Kui, Yang Yang, Zhao Min, Qiu Wen-Tao, Xin Yong-Jie, Zhou Zhi-Ling

机构信息

Department of Pharmacy, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, China.

Zhuhai Interventional Medical Center, Zhuhai Precision Medical Center, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai, China.

出版信息

Ann Transl Med. 2021 Aug;9(15):1253. doi: 10.21037/atm-21-2820.

DOI:10.21037/atm-21-2820
PMID:34532390
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421934/
Abstract

BACKGROUND

Tribble pseudokinase 3 () plays a key role in regulating the malignancy of many tumors. This study examined its function in cancer cells and explored the potential mechanisms of action.

METHODS

The expression of was examined in hepatocellular carcinomas (HCCs) using The Cancer Genome Atlas (TCGA) database. A lentivirus with a flag label was constructed and transfected into Huh7 and Hep3B human hepatoma cell lines to generate cells that stably overexpress . A small interfering RNA (siRNA) was designed to knockdown mRNA in HepG2 and Huh7. Cell viability and cell colony formation assays were conducted. Flow cytometry was performed to assess the cell cycle in cells overexpressing . Western blotting were performed to examine the expression of (Mitogen-activated protein kinase, MAPKK) (MEK), phosphorylated-MEK (p-MEK), extracellular signal-regulated kinase (ERK), and p-MEK in cells with knockdown. The correlation between and was assessed using co-immunoprecipitation assays and immunofluorescence.

RESULTS

was significantly overexpressed in advanced grade HCC tissues and was closely correlated with poor prognosis. overexpression promoted the cell growth and cell cycle but had little effect on migration capabilities in Huh7 and Hep3B cells. Conversely, knockdown of had slow down the cell growth in Huh7 and HepG2 cells detected by CCK8 and colony formation assay. The expression of and at both the protein and mRNA levels were downregulated when was knocked down. The protein expression of and were also downregulated upon silencing. is a transcript factor that is belongs to the SWI/SNF complex and has been shown to regulate many genes. Indeed, co-immunoprecipitation assays demonstrated that interacts with in the nucleus, suggesting that it may regulate in HCCs.

CONCLUSIONS

This study demonstrated that promotes the malignancy of HCC cells and its expression may be a potential diagnostic biomarker for HCC progression.

摘要

背景

Tribble假激酶3()在调节多种肿瘤的恶性程度中起关键作用。本研究检测了其在癌细胞中的功能,并探讨了潜在的作用机制。

方法

使用癌症基因组图谱(TCGA)数据库检测肝细胞癌(HCC)中 的表达。构建带有flag标签的慢病毒并转染到Huh7和Hep3B人肝癌细胞系中,以产生稳定过表达 的细胞。设计小干扰RNA(siRNA)以敲低HepG2和Huh7中的 mRNA。进行细胞活力和细胞集落形成测定。进行流式细胞术以评估过表达 的细胞中的细胞周期。进行蛋白质印迹以检测敲低 的细胞中丝裂原活化蛋白激酶(MAPKK)(MEK)、磷酸化MEK(p-MEK)、细胞外信号调节激酶(ERK)和p-MEK的表达。使用免疫共沉淀测定和免疫荧光评估 与 的相关性。

结果

在高级别HCC组织中显著过表达,且与预后不良密切相关。 过表达促进Huh7和Hep3B细胞的细胞生长和细胞周期,但对迁移能力影响不大。相反,通过CCK8和集落形成测定检测到,敲低 会减缓Huh7和HepG2细胞的细胞生长。敲低 时, 和 在蛋白质和mRNA水平的表达均下调。沉默 后, 和 的蛋白质表达也下调。 是一种转录因子,属于SWI/SNF复合物,已被证明可调节许多基因。事实上,免疫共沉淀测定表明 在细胞核中与 相互作用,表明它可能在HCC中调节 。

结论

本研究表明, 促进HCC细胞的恶性程度,其表达可能是HCC进展的潜在诊断生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/3539ab00569a/atm-09-15-1253-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/250c148ede5d/atm-09-15-1253-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/f65963baca10/atm-09-15-1253-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/d40175507b54/atm-09-15-1253-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/d398dfd627b7/atm-09-15-1253-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/3539ab00569a/atm-09-15-1253-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/250c148ede5d/atm-09-15-1253-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/f65963baca10/atm-09-15-1253-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/d40175507b54/atm-09-15-1253-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/d398dfd627b7/atm-09-15-1253-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02ea/8421934/3539ab00569a/atm-09-15-1253-f5.jpg

相似文献

1
Tribbles pseudokinase 3 () contributes to the progression of hepatocellular carcinoma by activating the mitogen-activated protein kinase pathway.Tribbles假激酶3()通过激活丝裂原活化蛋白激酶途径促进肝细胞癌的进展。
Ann Transl Med. 2021 Aug;9(15):1253. doi: 10.21037/atm-21-2820.
2
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway.TRIB3的下调通过MEK/ERK信号通路抑制卵巢癌的进展。
Cancer Cell Int. 2020 Aug 28;20:418. doi: 10.1186/s12935-020-01509-z. eCollection 2020.
3
Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.丙型肝炎病毒非结构蛋白3通过调节Tribbles同源物3/Akt信号通路实现病毒持续感染
J Virol. 2016 Jul 27;90(16):7231-7247. doi: 10.1128/JVI.00326-16. Print 2016 Aug 15.
4
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.TRIB3 通过与β-catenin 和 TCF4 相互作用来增加结直肠癌细胞干细胞的干细胞特征和肿瘤发生。
Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.
5
TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.TRIB3 促进肝癌生长并预测不良预后。
Cancer Biomark. 2020;29(3):307-315. doi: 10.3233/CBM-201577.
6
TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway.TRIB3 通过激活 MAPK 信号通路促进肾细胞癌细胞的增殖和侵袭。
Int J Biol Sci. 2019 Jan 1;15(3):587-597. doi: 10.7150/ijbs.29737. eCollection 2019.
7
Tribbles Pseudokinase 3 Contributes to Cancer Stemness of Endometrial Cancer Cells by Regulating β-Catenin Expression.Tribbles假激酶3通过调节β-连环蛋白表达促进子宫内膜癌细胞的干性。
Cancers (Basel). 2020 Dec 15;12(12):3785. doi: 10.3390/cancers12123785.
8
TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis.TRIB3 通过与 STAT3 相互作用促进癌症血管生成。
Curr Med Sci. 2022 Oct;42(5):932-940. doi: 10.1007/s11596-022-2655-8. Epub 2022 Oct 17.
9
Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.对丝裂原活化蛋白激酶激酶(MEK)抑制剂的耐药性与肝癌细胞中MEK/细胞外信号调节激酶通路的上调相关。
J Pharmacol Exp Ther. 2009 Jun;329(3):1063-70. doi: 10.1124/jpet.108.147306. Epub 2009 Mar 3.
10
PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells.PHD2 通过激活人肝癌细胞中的 Ras/Raf/MEK/ERK 和 JAK1/STAT3 通路发挥癌基因作用。
Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):37-45. doi: 10.1080/21691401.2019.1699806.

引用本文的文献

1
Downregulation of TRIB3 enhances the sensitivity of lung cancer cells to amino acid deprivation by suppressing AKT activation.TRIB3的下调通过抑制AKT激活增强肺癌细胞对氨基酸剥夺的敏感性。
Am J Cancer Res. 2024 Apr 15;14(4):1622-1633. doi: 10.62347/GLSY2976. eCollection 2024.
2
RBCK1 overexpression is associated with immune cell infiltration and poor prognosis in hepatocellular carcinoma.RBCK1过表达与肝细胞癌中的免疫细胞浸润及不良预后相关。
Aging (Albany NY). 2024 Jan 11;16(1):538-549. doi: 10.18632/aging.205393.
3
Comprehensive pan-cancer analysis unveils the significant prognostic value and potential role in immune microenvironment modulation of TRIB3.

本文引用的文献

1
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma.用于预测肝细胞癌的血清生物标志物
Cancers (Basel). 2021 Apr 2;13(7):1681. doi: 10.3390/cancers13071681.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Hepatocellular carcinoma.肝细胞癌。
全面的泛癌分析揭示了TRIB3的显著预后价值及其在免疫微环境调节中的潜在作用。
Comput Struct Biotechnol J. 2023 Nov 30;23:234-250. doi: 10.1016/j.csbj.2023.11.043. eCollection 2024 Dec.
4
Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme.细胞核内的 2 型转谷氨酰胺酶:细胞质酶的新表观遗传面貌。
Cell Mol Life Sci. 2023 Jan 25;80(2):52. doi: 10.1007/s00018-023-04698-8.
5
Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome.假激酶 NRP1 促进非洲锥虫转铁蛋白的内吞作用。
Sci Rep. 2022 Nov 3;12(1):18572. doi: 10.1038/s41598-022-22054-x.
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
4
Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer.Lnc-GAN1 表达与良好的生存相关,并通过海绵吸附 mir-26a-5p 来激活 PTEN 信号通路从而抑制非小细胞肺癌的肿瘤进展。
J Exp Clin Cancer Res. 2021 Jan 6;40(1):9. doi: 10.1186/s13046-020-01819-0.
5
The SWI/SNF subunit SMARCD3 regulates cell cycle progression and predicts survival outcome in ER+ breast cancer.SWI/SNF亚基SMARCD3调节细胞周期进程并预测雌激素受体阳性乳腺癌的生存结果。
Breast Cancer Res Treat. 2021 Feb;185(3):601-614. doi: 10.1007/s10549-020-05997-5. Epub 2020 Nov 12.
6
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs.SMARCD3 是 CAFs 中的一个潜在的预后标志物和治疗靶点。
Aging (Albany NY). 2020 Oct 28;12(20):20835-20861. doi: 10.18632/aging.104102.
7
Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?肝细胞癌(HCC)术前甲胎蛋白(AFP):这个50年的生物标志物仍与时俱进吗?
Transl Gastroenterol Hepatol. 2020 Oct 5;5:46. doi: 10.21037/tgh.2019.12.09. eCollection 2020.
8
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway.TRIB3的下调通过MEK/ERK信号通路抑制卵巢癌的进展。
Cancer Cell Int. 2020 Aug 28;20:418. doi: 10.1186/s12935-020-01509-z. eCollection 2020.
9
TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis.TRIB3 促进肝癌生长并预测不良预后。
Cancer Biomark. 2020;29(3):307-315. doi: 10.3233/CBM-201577.
10
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.TRIB3-EGFR 相互作用促进肺癌的进展并确定了一个治疗靶点。
Nat Commun. 2020 Jul 21;11(1):3660. doi: 10.1038/s41467-020-17385-0.